Pembrolizumab Plus Chemotherapy in Squamous Non–Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study

Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate...

Descripción completa

Detalles Bibliográficos
Autores principales: Novello, Silvia, Kowalski, Dariusz M., Luft, Alexander, Gümüş, Mahmut, Vicente, David, Mazières, Julien, Rodríguez-Cid, Jeronimo, Tafreshi, Ali, Cheng, Ying, Lee, Ki Hyeong, Golf, Alexander, Sugawara, Shunichi, Robinson, Andrew G., Halmos, Balazs, Jensen, Erin, Schwarzenberger, Paul, Pietanza, M. Catherine, Paz-Ares, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2023
Materias:
CLINICAL TRIAL UPDATES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082300/
https://www.ncbi.nlm.nih.gov/pubmed/36735893
http://dx.doi.org/10.1200/JCO.22.01990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082300/
https://www.ncbi.nlm.nih.gov/pubmed/36735893
http://dx.doi.org/10.1200/JCO.22.01990

Ejemplares similares